| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10051466 | The Journal of Urology | 2005 | 5 Pages |
Abstract
These results suggest that halofuginone is a potent inhibitor of WT progression. Because of its unique mode of action, halofuginone may decrease the treatment burden when combined with chemotherapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
JEHONATHAN H. PINTHUS, YUVAL SHEFFER, ARNON NAGLER, EDUARD FRIDMAN, YORAM MOR, OLGA GENINA, MARK PINES,